Policy Brief (Issue 16): Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?
Policy Brief (Issue 15): Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?
PolicyBrief (Issue 14): Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?
Research Report: Quality standards for health promotion and disease prevention services in Thailand: phase II
Research report: Proposal development for the revision of health screening programme as part of the Health Insurance Card Scheme for migrants in Thailand
Research Report: Developing Recommendation of Payment Mechanisms for Health Promotion and Disease Prevention in Thailand
Anxiety at First and Subsequent Pregnancies and Its Associated Factors: A Historical Cohort Study From Northeastern Thailand
Leaving No One Behind: Participatory Technology Appraisal as a Platform for Agenda Setting to Address Disparities in Access to Health Services in Thailand.
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
Policy Brief and Working Paper: Conducive Factors to the Development of Health Technology Assessment in Asia